Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
21.65
-0.60 (-2.70%)
At close: Jun 8, 2026, 4:00 PM EDT
21.72
+0.07 (0.32%)
After-hours: Jun 8, 2026, 7:40 PM EDT
Greenwich LifeSciences Employees
As of December 31, 2024, Greenwich LifeSciences had 8 total employees, including 4 full-time and 4 part-time employees. The number of employees increased by 1 or 14.29% compared to the previous year.
Employees
8
Change (1Y)
1
Growth (1Y)
14.29%
Revenue / Employee
n/a
Profits / Employee
-$2,783,822
Market Cap
317.78M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 8 | 1 | 14.29% | 4 | 4 |
| Dec 31, 2023 | 7 | 1 | 16.67% | 3 | 4 |
| Dec 31, 2022 | 6 | 0 | - | 3 | 3 |
| Dec 31, 2021 | 6 | 3 | 100.00% | 3 | 3 |
| Dec 31, 2020 | 3 | - | - | 1 | 2 |
Related Stocks
| Company Name | Employees |
|---|---|
| REGENXBIO | 371 |
| Abeona Therapeutics | 226 |
| Nautilus Biotechnology | 127 |
| Enanta Pharmaceuticals | 120 |
| Artiva Biotherapeutics | 104 |
| Verastem | 102 |
| Larimar Therapeutics | 71 |
| Lexeo Therapeutics | 59 |
GLSI News
- 7 days ago - Greenwich LifeSciences presents FLAMINGO-01 data at ASCO - TheFly
- 7 days ago - Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at ASCO Meeting 2026 - GlobeNewsWire
- 7 days ago - Greenwich LifeSciences provides update on 10-K filing - TheFly
- 7 days ago - Greenwich LifeSciences Provides Update Regarding Form 10-K Filing - GlobeNewsWire
- 17 days ago - Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing - GlobeNewsWire
- 5 weeks ago - Greenwich LifeSciences says Form 10-K ‘still being audited’ - TheFly
- 6 weeks ago - Greenwich LifeSciences Announces Acceptance of Abstract at ASCO 2026 - GlobeNewsWire
- 6 weeks ago - Greenwich LifeSciences receives noncompliance notification from Nasdaq - TheFly